CAGR Compound Annual Growth Rate

957
-1

Published on

Published in: Economy & Finance, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
957
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
9
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

CAGR Compound Annual Growth Rate

  1. 1. GlaxoSmithKlinePharmaceuticalSubmitted To,Prof. Ramesh .S
  2. 2. Type Public limited company LSE:Traded as NYSE:Industry Pharmaceutical, biotechnology Glaxo WellcomePredecessor(s) SmithKline BeechamFounded 2000 (London)Headquarters London, United Kingdom Chris Gent (Chairman)Key people Andrew Witty (Chief Executive) Pharmaceuticals, vaccines, oral healthcareProducts products, nutritional products, over-the-counter medicinesRevenue £28.392 billion (2010)[1]Net income £1.853 billion (2010)[1]Total equity £9.745 billion (2010)[2]Employees 96,500 (2010
  3. 3. Compound Annual GrowthRate - CAGR The year-over-year growth rate of an investment over a specified period of time. Formula for CAGR [{Current value of sales/value of sales from base year]1/n -1}* 100]
  4. 4. GLAXOSMITHKLINEPHARMACEUTICALS (CAGR) Year 2010 2009 2008 2007 2006Net Sales 2,125.20 1,884.14 1,676.36 1,578.58 1,541.93 PAT 563.69 512.29 576.57 537.66 545.51 CAGR 8.35% 5.14% 2.11% 0.59% (Sales) CAGR 0.82% -1.56% 1.39% -0.36% (PAT)
  5. 5. 10.00% 8.00% 6.00% 4.00% CAGR (Sales) CAGR (PAT) 2.00% 0.00% 2010 2009 2008 2007-2.00%-4.00%
  6. 6. CAGR of Industry (Sales) Year 2010 2009 2008 2007 2006RANBAXY 5,646.37 4,781.59 4,652.04 4,293.02 4,165.12 LUPIN LTD 3,690.09 2,954.70 2,575.39 1,985.79 1,652.93DR.REDDYS 4,395.60 3,999.50 3,343.89 3,783.26 2,003.26 LAB Glaxos 2,125.20 1,884.14 1,676.36 1,578.58 1,541.93 mith Total 15857.26 13619.93 12247.66 11640.65 9363.24 CAGR 14.08% 9.82% 6.94% 5.59%
  7. 7. CAGR of Industry (PAT) Year 2010 2009 2008 2007 2006RANBAXY 1,148.73 571.98 -1,044.80 617.72 380.54LUPIN LTD 648.93 416.97 443.38 302.06 182.72DR.REDD 846.10 560.90 475.22 1,176.86 YS LAB 211.12Glaxos 563.69 512.29 576.57 537.66 545.51 mith TOTAL 3207.45 2062.14 450.37 2634.3 1319.89 CAGR 24.85% 11.80% -23.57% 18.86%
  8. 8. Industry Vs. Glaxosmith YEAR 2010 2009 2008 2007Glaxosmith 8.35% 5.14% 2.11% 0.59% Industry 14.08% 9.82% 6.94% 5.59% 16.00% 14.00% 12.00% 10.00% 8.00% Glaxosmith 6.00% Industry 4.00% 2.00% 0.00% 2010 2009 2008 2007
  9. 9. Thank You

×